PSUMaryDom Profile Banner
Mary Dominiecki Profile
Mary Dominiecki

@PSUMaryDom

Followers
222
Following
8K
Media
45
Statuses
749

Healthcare market researcher, lobular breast cancer survivor, mom of 3 boys, aka Mama Coco (RL)

Exton, PA
Joined April 2021
Don't wanna be here? Send us removal request.
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
On #NationalCancerSurvivorsDay, I can't help but reflect on everything I went through. Stage 2b lobular breast cancer detected on ultrasound but not mammogram. Chemo, DMX with DIEP flap reconstruction, radiation, and been on an AI ever since (8y). Greatful to be here!.
1
0
2
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @fumikochino: "Treatment preferences between survival & quality of life and their association with clinical outcomes in older adults wit….
0
8
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @ZiadBakouny: Congratulations to @YJanjigianMD on delivering a plenary talk on a practice-changing trial in the peri-operative treatment….
0
5
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @VJOncology: 🎥 NEW from #ASCO25! Eric Jonasch (@MDAndersonNews) shares 5-year LITESPARK-004 follow-up results. Belzutifan (HIF-2α inhibi….
0
1
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @UGrewalMD: @MyriamChalabi with an excellent discussion on the ATOMIC plenary at #ASCO25.Several unanswered questions:.❓Is single agent….
0
6
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @doctorpemm: #ASCO25 Key Takeaways for #PlenarySession #2 @ASCO - #NIVOPOSTOP study H&N SCC | n=680 ; Primary endpoint = DFS https://t.c….
0
2
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @Larvol: Here are the top trials from day 1 of @ASCO 2025. Follow us and get the latest #ASCO25 updates: #LARV….
0
22
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
#ASCO25 did anyone see Garrett's on the exhibitor floor yet? If so, where?.
0
0
1
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @VincentRK: 4) Relapsed Myeloma - Refractory Second or Higher Relapse #ASCO25
Tweet media one
0
10
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @VincentRK: 3) Relapsed Myeloma - First relapse. .#ASCO25
Tweet media one
0
10
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @VincentRK: 2) Newly Diagnosed myeloma transplant eligible. #ASCO25
Tweet media one
0
16
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @VincentRK: My Updated Myeloma Treatment Algorithms. #ASCO25.Bookmark!. Presented at COMy. 1) Newly Diagnosed myeloma transplant ineli….
0
138
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @GIMedOnc: #ASCO2025.🚨 BREAKWATER OS data lands—and it must redefine 1L standard of care in BRAF V600E-mutant mCRC. EC + mFOLFOX6 vs SO….
0
56
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @DrSGraff: Kicking off breast sessions #ASCO25 with the data that Black patients with breast cancer continue to have worse overall survi….
0
20
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @SuyogCancer: 🚨 #ASCO25 Update 🚨.🧬 Sacituzumab govitecan (SG) + pembrolizumab.vs.💉 Chemo + pembro in 1L PD-L1+ mTNBC.📊 ASCENT-04 / KEYNO….
0
37
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @GIMedOnc: #ASCO25 . DESTINY-Gastric04 sets a new 2L standard for HER2+ gastric/GEJ cancer. T-DXd vs Ramucirumab/Paclitaxel in post-tras….
0
27
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
Completely agree with this! Still recovering from knee surgery so sneakers it is!.Hack for scheduling meetings - as other time zones to outlook calendar. It helps me not schedule things with backwards conversion:).
@DDoroshow
Deborah Doroshow
@DDoroshow
2 months
As my thoughtful colleagues provide advice for #ASCO25 attendees, here’s a list of stupid stuff to avoid (guilty as charged) #fiASCO. 1. Wearing cute shoes. Just no. 2. Scheduling meetings in the right time zone-I screw this up and have overlapping meetings at least once a year.
0
0
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
2 months
RT @KrishanJethwa: 🚨DYNAMIC-III🚨. 🔎R0 resected stage 3 colon cancer, post-op ctDNA +. Randomized SoC vs intensified Systemic therapy.⛔️No i….
0
15
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
1 year
RT @hoperugo: #ASCO24 @Dr_RShatsky fabulous presentation of @ISPY2trial block A neoadjuvant Dato/Durva in MMP hi risk HR+ and TNBC. Hi pCR….
0
9
0
@PSUMaryDom
Mary Dominiecki
@PSUMaryDom
1 year
RT @to_be_elizabeth: 📌 Elucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer. Great presentation by @ErinCo….
0
5
0